APT Medical Inc - Asset Resilience Ratio
APT Medical Inc (688617) has an Asset Resilience Ratio of 8.63% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 688617 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2025)
This chart shows how APT Medical Inc's Asset Resilience Ratio has changed over time. See 688617 equity to assets ratio to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down APT Medical Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of APT Medical Inc.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥296.01 Million | 8.63% |
| Total Liquid Assets | CN¥296.01 Million | 8.63% |
Asset Resilience Insights
- Limited Liquidity: APT Medical Inc maintains only 8.63% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
APT Medical Inc Industry Peers by Asset Resilience Ratio
Compare APT Medical Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351 |
Medical Devices | 49.23% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 5.73% |
|
Shenzhen Lifotronic Technology Co
SHG:688389 |
Medical Devices | 2.53% |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186 |
Medical Devices | 0.84% |
|
Eurobio Scientific SA
PA:ALERS |
Medical Devices | 10.52% |
Annual Asset Resilience Ratio for APT Medical Inc (2021–2025)
The table below shows the annual Asset Resilience Ratio data for APT Medical Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 6.85% | CN¥250.49 Million ≈ $36.65 Million |
CN¥3.66 Billion ≈ $534.88 Million |
+4.52pp |
| 2023-12-31 | 2.33% | CN¥60.00 Million ≈ $8.78 Million |
CN¥2.57 Billion ≈ $376.51 Million |
-37.26pp |
| 2022-12-31 | 39.59% | CN¥881.34 Million ≈ $128.97 Million |
CN¥2.23 Billion ≈ $325.73 Million |
-5.80pp |
| 2021-12-31 | 45.39% | CN¥913.72 Million ≈ $133.71 Million |
CN¥2.01 Billion ≈ $294.58 Million |
-- |
About APT Medical Inc
APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. It offers electrophysiology products, such as navigation systems, navigated catheters, mapping catheters, ablation catheters, transseptal needles and sheaths, and steerable sheaths; and interventional cardiology and peripheral products, including access, diagno… Read more